183 related articles for article (PubMed ID: 36523284)
1. [Autoimmune lymphoproliferative syndrome: a case report].
Youssif HB; Ailal F; Benhsaien I; Bakkouri JE; Jeddane L; Maani KE; Bousfiha AA
Pan Afr Med J; 2022; 43():61. PubMed ID: 36523284
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
Paskiewicz A; Niu J; Chang C
Autoimmun Rev; 2023 Nov; 22(11):103442. PubMed ID: 37683818
[TBL] [Abstract][Full Text] [Related]
3. [Non-malignant, non-infectious lymphoproliferation: challenges in the diagnosis and treatment of autoimmune lymphoproliferative syndrome].
Molnár E; Kovács G; Varga L; Tasnády S; Bors A; Tankó L; Csabán D; Kapócs K; Nemes-Nagy Z; Andrikovics H
Orv Hetil; 2022 Jan; 163(4):123-131. PubMed ID: 35066491
[TBL] [Abstract][Full Text] [Related]
4. [A case of autoimmune lymphoproliferactive syndrome and literature review].
Liu L; Hu J; Ma J; Li X; Li F; Li C
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):923-6. PubMed ID: 25619350
[TBL] [Abstract][Full Text] [Related]
5. Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.
George LA; Teachey DT
Paediatr Drugs; 2016 Aug; 18(4):261-72. PubMed ID: 27139496
[TBL] [Abstract][Full Text] [Related]
6. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.
Teachey DT
Curr Opin Pediatr; 2012 Feb; 24(1):1-8. PubMed ID: 22157362
[TBL] [Abstract][Full Text] [Related]
7. [Advances in the knowledge and management of autoimmune lymphoproliferative syndrome].
Garrido Colino C
An Pediatr (Barc); 2014 Feb; 80(2):122.e1-7. PubMed ID: 24055319
[TBL] [Abstract][Full Text] [Related]
8. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
Li P; Huang P; Yang Y; Hao M; Peng H; Li F
Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
[TBL] [Abstract][Full Text] [Related]
9. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.
Cayrol J; Garrido Colino C
J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735
[TBL] [Abstract][Full Text] [Related]
10. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders.
Failing C; Blase JR; Walkovich K
Rheum Dis Clin North Am; 2023 Nov; 49(4):841-860. PubMed ID: 37821199
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD.
Gu H; Chen Z; Ma J; Wang J; Zhang R; Wu R; Wang T
Int J Immunopathol Pharmacol; 2021; 35():20587384211025934. PubMed ID: 34187243
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune lymphoproliferative syndrome: an update and review of the literature.
Shah S; Wu E; Rao VK; Tarrant TK
Curr Allergy Asthma Rep; 2014 Sep; 14(9):462. PubMed ID: 25086580
[TBL] [Abstract][Full Text] [Related]
14. The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders.
Oliveira Mendonça L; Matucci-Cerinic C; Terranova P; Casabona F; Bovis F; Caorsi R; Fioredda F; Palmisani E; Grossi A; Guardo D; Bustaffa M; Volpi S; Ceccherini I; Ravelli A; Dufour C; Miano M; Gattorno M
Rheumatology (Oxford); 2022 Feb; 61(2):696-704. PubMed ID: 33909886
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune Lymphoproliferative Syndrome: An Overview.
Matson DR; Yang DT
Arch Pathol Lab Med; 2020 Feb; 144(2):245-251. PubMed ID: 30958694
[TBL] [Abstract][Full Text] [Related]
16. [Familial splenomegaly as a first clinical sign of autoimmune lymphoproliferative syndrome].
Bilbao Aburto A; Arana Aguirre N; García Martínez JM; Astigarraga Aguirre I; Allende LM
An Pediatr (Barc); 2010 Apr; 72(4):278-81. PubMed ID: 20227933
[TBL] [Abstract][Full Text] [Related]
17. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
[TBL] [Abstract][Full Text] [Related]
18. How I treat autoimmune lymphoproliferative syndrome.
Rao VK; Oliveira JB
Blood; 2011 Nov; 118(22):5741-51. PubMed ID: 21885601
[TBL] [Abstract][Full Text] [Related]
19. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
Front Immunol; 2018; 9():2400. PubMed ID: 30386345
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
